Latest news with #JordanWalker
New York Times
7 hours ago
- Sport
- New York Times
Cardinals mailbag: Trade deadline, roster construction and playing decisions
After a woeful two weeks, the St. Louis Cardinals thrust themselves back on track with a three-game sweep over the Chicago White Sox. Still, plenty of questions remain for the club ahead of a pivotal seven-game homestand against two division foes. The Cardinals (40-35) will head back to Busch Stadium for a three-game series against the Cincinnati Reds before taking on the Chicago Cubs for the first time this year for four games. Advertisement How will the club's upcoming stretch impact impending decisions about the trade deadline, roster construction and playing time? You asked; we did our best to answer. Let's get to it in our latest subscriber mailbag. Note: Submitted questions have been edited for clarity and length. EXTRA INNINGS NOOT-BOMB! 💣 — St. Louis Cardinals (@Cardinals) June 20, 2025 The Cardinals have an awkward roster. Three catchers, about a million DHs and, somehow, not one (enticing) right-handed-hitting outfielder at any level after Jordan Walker. There is also the big second-base logjam with Thomas Saggese already squeezed out by Brendan Donovan and Nolan Gorman, with JJ Wetherholt right on his heels, torching his way through Double A. Is this just a result of the reset (retool? rebuild?) season, where we're seeing everything being thrown at the wall to find out what sticks? Is the front office concerned with this as the trade deadline approaches? Does it want to wait until the offseason so it can have a better grasp on the talent it has on hand before trading away some of its depth? — Evan O. You nailed it. The roster construction is questionable at best, but to the team's credit, it has been able to outdo expectations. You bring up a strong point about the plethora of middle infielders, and you're also correct that some of this logjam is a byproduct of the team's reset plan. The organization can't make decisions on which players to keep if it doesn't have a full understanding of what each player is (and finding out was the primary objective of this season). The front office isn't overly concerned about this, mainly because it won't be John Mozeliak's problem. Chaim Bloom will inherit the roster come November — and the assortment of challenging decisions that will come with it. It's improbable a major trade involving any of the young players or top prospects will occur at the deadline. The Cardinals wanted a full season of player performance — not half of one — before making any long-term decisions. That shouldn't change regardless of how the team performs over the next month. Advertisement That's not to say the Cardinals won't be active at the deadline, and we'll get to that later. But for those of you hoping to see some of the middle infield or catching surplus traded away this July, shift your focus to the offseason. If St. Louis decides to go that route, it will likely be a Bloom decision. The season has gone better than expected, but the team has hit a rough patch in June. If the team is sitting around .500 going into the trade deadline, do you have a feel as to whether it will buy or sell? I understand the reasoning for both, but it'd be a great opportunity to move someone like Miles Mikolas or Erick Fedde to make space for Michael McGreevy and give him a full runway for the rest of the season. — Brent M. Will the Cardinals be buyers at the deadline or will they stick to the mantra of seeing young kids play? Any chance they sell for some pitching? — Michael N. It's still too early to tell if the Cardinals will buy or sell. We'll have a better indication of where things stand ahead of the All-Star break, but that is still four weeks away, and a lot can change in the standings between now and then. One thing we do know: Regardless of whether the team buys or sells, the priority will remain the future. If the Cardinals add at the deadline, they will do so incrementally. If they sell, it will likely involve players on expiring deals. The Cardinals indeed could shop Fedde, who is in the final season of his $7.5 million contract, to make room for McGreevy in the rotation, but only if they feel comfortable with their pitching depth. Trading Mikolas would be much more difficult, as he's owed more ($17.5 million this year) and has a full no-trade clause. Steven Matz could also be a trade candidate, but St. Louis would have to find a viable solution to backfill his spot in the bullpen, especially if it's contending. There is also a chance the Cardinals become sellers but make themselves more competitive in the process. How is that possible, you ask? The 2024 Detroit Tigers serve as an ideal blueprint. The Tigers traded four players in the last deadline — Jack Flaherty, Mark Canha, Andrew Chafin and Carson Kelly — but elected to keep eventual American League Cy Young Award winner Tarik Skubal. Those decisions opened the door for an abundance of young talent, which propelled Detroit to a playoff berth. That's a path the Cardinals would gladly take this year. Who's making the final call on trades, or even the organizational philosophy to buy or sell, and to what degree: Mozeliak or Bloom? — Gregory D. How much, if any, will Bloom influence the trade deadline decisions this year? — Robert T. From a baseball operations standpoint, it's Mozeliak running the show at the deadline. He remains in charge of the major-league decisions for the rest of the season while Bloom oversees the first year of a multiyear renovation plan in the minor leagues. Inner rumblings within the organization say Bloom will be available for feedback should any of Mozeliak's potential trades impact players not on expiring contracts, but it remains to be seen just how active he will be permitted to be in the decision-making process. Advertisement As to what degree, that's not up to Bloom or Mozeliak. That's strictly an ownership call, and there is no telling what chairman Bill DeWitt Jr. will do, especially if the Cardinals look to be contenders at the end of July. The team has prepared for a recession period due to a predicted decline in ticket sales and the restructuring of its television deal. It has also pledged a substantial relocation of funds to the minor leagues as part of a long-needed overhaul of the player development system. That's why payroll was cut drastically before the season and why the organization attempted to offload heavy contracts such as Nolan Arenado's. It's highly unlikely ownership will switch course halfway through the year. That means whatever trades the Cardinals do make this year won't register much on the Richter scale. If they buy, expect moves to improve immediate roster needs, but not anything that will impact 2026 and beyond. If they sell, expect players on expiring deals to be the ones who are shopped. It seems to me we're at a point where trading the (impending) free-agent pitchers is coming closer to reality. It seems the odds of any of them coming back are minimal. That's a huge chunk of a pitching staff to replenish. Do you foresee the team really being able to replace them in the offseason? — Brian S. Which prospects are setting themselves apart to be considered top prospects for the organization? — John H. You are right that it's improbable the Cardinals bring back Mikolas, Fedde or Matz. I think the club can replenish these vacancies, but it would do so internally. McGreevy is basically a lock for a spot in the rotation next year. Quinn Mathews is back with Triple-A Memphis after missing six weeks on the injured list, and the organization remains quite high on him. Tink Hence was also recently activated off the IL and transferred to Double-A Springfield, and though there are some concerns over his sustainability as a starting pitcher, the Cardinals will continue to give him ample opportunity to build up. St. Louis took a significant hit when 2022 first-round pick Cooper Hjerpe underwent Tommy John surgery in April, but that makes the club's experiments with Andre Pallante and Matthew Liberatore that much more important. If either pitcher can prove his ability in the rotation this year, that's one less spot the organization has to worry about filling. One pitching prospect who has really excited the organization is Tekoah Roby. The 23-year-old (who came to St. Louis from the Texas Rangers as one of the returns for Jordan Montgomery and Chris Stratton in 2023) has exceptional stuff, as evidenced by his 66 strikeouts over 57 1/3 innings this year. Roby made 10 starts for Springfield before being promoted to Memphis at the beginning of June. He'll need to continue racking up innings — injuries have shortened his last two seasons, and he has not logged more than 60 innings in a season since 2022. But he remains a tantalizing prospect and is an early contender to break into the rotation in 2026. Tekoah Roby was nearly untouchable tonight: 5.2 IP, 4 H, 2 ER, 0 BB, 11 K — Springfield Cardinals (@Sgf_Cardinals) May 17, 2025 There's all the talk of the runway for players like Walker and Gorman, but does that same idea also apply to Lars Nootbaar? He has struggled recently, and I'm honestly not sure if I trust his record, especially considering his inability to stay healthy. — Dan H. If Walker and Gorman were priority No. 1 this season, consider Nootbaar priority 1A. Nootbaar was always under the runway umbrella, though the concern from the organization was more health-related than performance. To your point about his injury track record: In four seasons in the big leagues, Nootbaar played no more than 117 games and spent significant time on the IL in each of his last three seasons. Nootbaar has done a nice job staying on the field this year, and it's been a top priority for him. He knows the organization will be evaluating his performance this year before deciding what his role will be in the future. That's why manager Oli Marmol has continued to play Nootbaar despite arguably the worst slump of the 27-year-old's career. Similar to Walker and Gorman, the Cardinals need to know if Nootbaar can overcome and make adjustments at the major-league level, and the only way to find that out is by playing him every day. Advertisement To what extent are we going to be inundated with Arenado trade rumors in the coming months? — Keith H. Probably not to the extent of last offseason (which I'm still recovering from), but expect Arenado's name to still pop up in rumors as we inch closer to July. However, the likelihood of Arenado being traded is not high. As we learned over the winter, Arenado's full no-trade clause has greatly slimmed potential landing spots. His performance also hasn't increased his value. In fact, his .686 OPS would likely serve as a deterrent for a contending team, and that's to say nothing of the money still owed on his contract. Still, you can never say never in a situation like this. But an Arenado trade, if it ever does occur, seems much more probable this winter than this summer. (Photo of Michael McGreevy: Geoff Stellfox / Getty Images)
Yahoo
17 hours ago
- Sport
- Yahoo
Arenado hits 350th homer, drives in go-ahead run in 10th to help Cardinals sweep doubleheader
St. Louis Cardinals' Lars Nootbaar (21) celebrates with teammates after hitting a solo home run during the 10th inning in the second baseball game of a doubleheader against the Chicago White Sox, Thursday, June 19, 2025. (AP Photo/Nam Y. Huh) St. Louis Cardinals catcher Pedro Pagés, left, celebrates with relief pitcher Andre Granillo after they defeated the Chicago White Sox in the second baseball game of a doubleheader Thursday, June 19, 2025. (AP Photo/Nam Y. Huh) St. Louis Cardinals' Lars Nootbaar celebrates after hitting a solo home run during the 10th inning in the second baseball game of a doubleheader against the Chicago White Sox, Thursday, June 19, 2025. (AP Photo/Nam Y. Huh) St. Louis Cardinals' Jordan Walker (18) celebrates with teammates after scoring on a one-run single by Nolan Arenado during the 10th inning in the second baseball game of a doubleheader against the Chicago White Sox Thursday, June 19, 2025. (AP Photo/Nam Y. Huh) St. Louis Cardinals' Nolan Arenado hits a one-run single during the 10th inning in the second baseball game of a doubleheader against the Chicago White Sox, Thursday, June 19, 2025. (AP Photo/Nam Y. Huh) St. Louis Cardinals' Nolan Arenado hits a one-run single during the 10th inning in the second baseball game of a doubleheader against the Chicago White Sox, Thursday, June 19, 2025. (AP Photo/Nam Y. Huh) St. Louis Cardinals' Lars Nootbaar (21) celebrates with teammates after hitting a solo home run during the 10th inning in the second baseball game of a doubleheader against the Chicago White Sox, Thursday, June 19, 2025. (AP Photo/Nam Y. Huh) St. Louis Cardinals catcher Pedro Pagés, left, celebrates with relief pitcher Andre Granillo after they defeated the Chicago White Sox in the second baseball game of a doubleheader Thursday, June 19, 2025. (AP Photo/Nam Y. Huh) St. Louis Cardinals' Lars Nootbaar celebrates after hitting a solo home run during the 10th inning in the second baseball game of a doubleheader against the Chicago White Sox, Thursday, June 19, 2025. (AP Photo/Nam Y. Huh) St. Louis Cardinals' Jordan Walker (18) celebrates with teammates after scoring on a one-run single by Nolan Arenado during the 10th inning in the second baseball game of a doubleheader against the Chicago White Sox Thursday, June 19, 2025. (AP Photo/Nam Y. Huh) St. Louis Cardinals' Nolan Arenado hits a one-run single during the 10th inning in the second baseball game of a doubleheader against the Chicago White Sox, Thursday, June 19, 2025. (AP Photo/Nam Y. Huh) CHICAGO (AP) — Nolan Arenado hit his 350th homer in the third inning and drove in the go-ahead run in the 10th to help the St. Louis Cardinals beat Chicago 8-6 on Thursday night to sweep a doubleheader and hand the White Sox their eighth straight loss. Rookie Andre Granillo, who got the final out in the seventh for his first career victory in the first game, pitched a scoreless 10th for his first save in his fourth appearance. JoJo Romero (3-3) worked a scoreless ninth for the victory. Advertisement Arenado hit the milestone homer following a three-run shot by Alec Burleson in the third and finished 3 for 5. He's the seventh player with 350 homers and 10-plus Gold Gloves. Willson Contreras, who homered and drove in three runs to help St. Louis rally for a 5-4 win in the opener, had a two-out two-run double in the fourth for a 6-1 lead. Andrew Benintendi hit his third career grand slam with two outs in the seventh to cap a five-run inning as Chicago tied it at 6. Dan Altavilla (0-1) struck out Burleson to begin the 10th. Arenado singled to score automatic runner Jordan Walker, but was thrown out trying for a double. Lars Nootbaar added his ninth homer for an insurance run. Advertisement Victor Scott II singled and stole his 20th base and Willson Contreras was hit by a pitch ahead of Burleson's seventh homer. Ryan Noda homered leading off the second against St. Louis starter Michael McGreevy for his first hit with Chicago. St. Louis has won three straight. Key moment Arenado threw home on a grounder by Vinny Capra to get Tauchman for the second out in the ninth. Miguel Vargas grounded out after Capra stole second to force extra innings. Key stat St. Louis is 8-4 in six doubleheaders this season, while Chicago was playing its first doubleheader. Up next RHP Andre Pallante (4-3, 4.83) starts Friday for the Cardinals against the visiting Reds and RHP Brady Singer (7-4, 4.34). White Sox RHP Davis Martin (2-7, 3.79) starts Friday in Toronto against RHP Spencer Turnbull (1-0, 2.08). ___ AP MLB:
New York Times
4 days ago
- Sport
- New York Times
Cardinals' June skid continues after series loss to Brewers: ‘We're keeping our heads up'
MILWAUKEE — With two on and nobody out in the top of the ninth, the bottom three hitters for the St. Louis Cardinals had a prime opportunity to stop their team's worst skid of the season. Jordan Walker, Victor Scott II and Masyn Winn all had chances to drive in at least the tying run against Milwaukee Brewers closer Trevor Megill. All three struck out, stranding the tying run 90 feet from home. The Brewers beat the Cardinals 3-2, besting their division opponent in three of four games to take the series. The Cardinals, who held the best record in baseball in May at 19-8, have lost seven of their last eight games and have just four wins in June. Advertisement St. Louis (37-35) knew coming into the month that June would present several challenges. The lack of scheduled off days, the strength of the opposing schedule and various minor injuries to key players have contributed to their slide. But their series loss in Milwaukee capped what has been their worst performing stretch of the season thus far. With trade deadline decisions on the line, they know they need to turn it around — and urgently. 'There's no excuse,' Nolan Arenado said after Sunday's loss. 'Last month was a great month. This month is a tough month so far. Obviously, no days off makes it even tougher, but there are no excuses — everyone has to go through that. We're keeping an even-keel mindset, but there's no doubt that when we play division rivals, we have to win those series.' Yeli ties it with No. 1⃣4⃣ on the year ⭐ — Milwaukee Brewers (@Brewers) June 15, 2025 The first two weeks of June highlighted several concerns about what could be perceived as a flawed roster construction. Pedro Pagés has emerged as the far superior defensive catcher, but the Cardinals can't justify leaving Iván Herrera and his .928 OPS on the bench, so they've turned to using him as their designated hitter. That role was originally intended for Nolan Gorman, who saw his playing time cut as Brendan Donovan solidified himself as the starting second baseman. But as several players (such as Lars Nootbaar and Scott) find themselves mired in slumps, manager Oli Marmol has found it difficult to justify sitting Gorman, especially when he's hitting .344 with three homers and a 1.120 OPS in June. Marmol can start Gorman at second base and move Donovan to a corner outfield spot, but that comes with the sacrifice of defense, something that anchored the Cardinals through the first two months of the season. It doesn't help that two of their better defensive outfielders — Nootbaar and Scott — have seen their offensive production virtually fall off a cliff. Nootbaar is 5-for-44 this month with an alarming 19 strikeouts. After a four-strikeout game in Friday's 3-2 loss, the Cardinals decided to give Nootbaar a mental reset and pledged to use him only as a late-inning defensive replacement or a pinch runner until Tuesday, when St. Louis takes on the Chicago White Sox for the first of three games. Advertisement Scott hasn't fared much better. He's just 5-for-34 with 13 strikeouts. But in a season in which Marmol has been tasked with prioritizing player development, sending Scott down is not an option. It also isn't like St. Louis has any better alternatives. It's fair to question the team's bench construction. It is carrying three catchers, though Yohel Pozo is the best right-handed bench bat over Jose Barrero and Luken Baker. Barrero's primary role as the team's 26th man is essentially to provide coverage for Masyn Winn. The Cardinals also played the majority of the week on short depth, with Donovan (sprained toe) unavailable for four games. That has not left Marmol with many options to switch up playing time. 'That's the challenge,' Marmol said. 'You have guys that aren't in good spots who you're trying to stay away from and get some time off to and then other guys that are in a similar spot, where they're trying to finish out, but they have to plow through it, especially in a spot like this.' The Cardinals received a boost when Walker (left wrist inflammation) returned from the injured list Saturday, and they expect to have Nootbaar back in the starting lineup Tuesday (though they'll debate whether he stays in the leadoff spot). But perhaps their biggest aid will be their off day Monday. St. Louis played 14 consecutive games and will play 16 straight beginning Tuesday. Already, the team is contemplating when it will return to a temporary six-man rotation, with Michael McGreevy again the leading candidate to take that spot when he's eligible to be recalled on June 24. 'We knew this would be tough,' Marmol said. 'When you look at May, we were able to run out our guys almost every day, with every Thursday being (a scheduled off day). We've had to mix and match a little more and give guys opportunities to see what they can do with it. But we knew it was going to be a tough stretch. The guys are playing hard. Tomorrow's off day is a timely one; we'll get to regroup and then get back at it.' (Photo of Victor Scott II: Jeff Hanisch / Imagn Images)
Yahoo
12-06-2025
- Business
- Yahoo
Inter Scientific Supports Jupiter Research in Achieving EU Certification for First Handheld Liquid Inhalation Device
LIVERPOOL, United Kingdom, June 12, 2025 (GLOBE NEWSWIRE) -- Inter Scientific is pleased to announce its role, in collaboration with Jupiter Research LLC, as the regulatory partner for the first handheld Liquid Inhalation Device to receive regulatory approval under Regulation (EU) 2017/745 (EU MDR). This regulatory milestone marks a significant step forward in the medical device landscape and opens the door for wider global access to innovative inhalation technologies. Jupiter Research, a pioneering company in the liquid vaporizer space, identified early in its development journey the importance of an expert regulatory partner. After an initial review process, Jupiter selected Inter Scientific based on its ability to meet the demands and complexity of the EU MDR. This decision proved instrumental in Jupiter's successful regulatory approval. 'Jupiter recognised very early in the process that external support would be beneficial,' stated Jupiter's Senior Director of Engineering, Jordan Walker. 'We chose Inter Scientific based on their expertise and felt they were efficient and professional throughout the contract, helping us achieve our goals and gain regulatory approval.' Walker continued, 'Inter Scientific provided expertise in the creation of the device's comprehensive Technical File, development of the required Quality Management System documentation, and delivery of tailored educational services to Jupiter's internal teams. This approach enabled a streamlined path to regulatory compliance.' David Lawson, Executive Director at Inter Scientific, commented:'At every stage of this rigorous certification process, Inter Scientific maintained a customer-focused approach, working closely with the Jupiter team and delivering timely, professional, and accurate support. We're proud to be recognised as a key contributor to this success and look forward to building on this achievement through continued collaboration on future regulatory initiatives.' Inter Scientific's in-depth understanding of the regulatory framework helped Jupiter design the device in line with medical classification requirements, prepare the necessary documentation, and respond effectively to regulatory feedback, which resulted in the successful approval of a first of its kind device now poised to make its mark in global healthcare. About Inter ScientificInter Scientific is an independent, accredited contract research organisation (CRO) providing regulatory science, product testing, and compliance services across highly regulated industries. With over a decade of experience, we support clients in the medical device, pharmaceutical, nicotine product, cosmetic, and novel food sectors. Inter Scientific operates to the highest quality standards, holding ISO/IEC 17025 accreditation and operating in accordance with Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP). Our expert team delivers scientifically robust, regulatory-ready data and strategic guidance to help clients navigate complex global regulations and bring compliant products to market with confidence. Inter Scientific Media Contact Razieh Alipour Digital Marketing Content in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
04-06-2025
- Business
- Associated Press
Kansas City Royals and St. Louis Cardinals meet in game 2 of series
Kansas City Royals (32-29, fourth in the AL Central) vs. St. Louis Cardinals (33-27, second in the NL Central) St. Louis; Wednesday, 7:45 p.m. EDT PITCHING PROBABLES: Royals: Noah Cameron (2-1, 1.05 ERA, 0.82 WHIP, 16 strikeouts); Cardinals: Miles Mikolas (4-2, 3.90 ERA, 1.25 WHIP, 34 strikeouts) BETMGM SPORTSBOOK LINE: Cardinals -131, Royals +110; over/under is 8 1/2 runs BOTTOM LINE: The Kansas City Royals lead 1-0 in a three-game series with the St. Louis Cardinals. St. Louis has a 19-9 record in home games and a 33-27 record overall. The Cardinals have the third-best team batting average in MLB play at .259. Kansas City is 32-29 overall and 13-16 in road games. The Royals have the seventh-ranked team batting average in the AL at .248. Wednesday's game is the fifth time these teams match up this season. The season series is tied 2-2. TOP PERFORMERS: Nolan Arenado has 10 doubles, a triple and six home runs for the Cardinals. Pedro Pages is 3 for 29 with two home runs over the past 10 games. Vinnie Pasquantino leads the Royals with eight home runs while slugging .399. Maikel Garcia is 13 for 40 with a double, a triple and seven RBIs over the past 10 games. LAST 10 GAMES: Cardinals: 6-4, .235 batting average, 4.66 ERA, outscored by 13 runs Royals: 4-6, .263 batting average, 4.03 ERA, outscored by eight runs INJURIES: Cardinals: Jordan Walker: 10-Day IL (wrist), Zack Thompson: 60-Day IL (lat) Royals: Maikel Garcia: day-to-day (thumb), Lucas Erceg: 15-Day IL (back), Cole Ragans: 15-Day IL (groin), Alec Marsh: 60-Day IL (shoulder), James McArthur: 60-Day IL (elbow), Hunter Harvey: 15-Day IL (shoulder), Sam Long: 15-Day IL (elbow), Kyle Wright: 15-Day IL (shoulder) ___ The Associated Press created this story using technology provided by Data Skrive and data from Sportradar.
